The translocation of protein toxins into a cell relies on a myriad of protein-protein interactions. One such group of toxins are enzymatic E colicins, protein antibiotics produced by Escherichia coli in times of stress. These proteins subvert ordinary nutrient uptake mechanisms to enter the cell and unleash nuclease activity. We, and others, have previously shown that uptake of ColE9 (colicin E9) is dependent on engagement of the OM (outer membrane) receptors BtuB and OmpF as well as recruitment of the periplasmic protein TolB, forming a large supramolecular complex. Intriguingly, colicins bind TolB using a natively disordered region to mimic the interaction of TolB with Pal (peptidoglycan-associated lipoprotein). This is thought to trigger OM instability and prime the system for translocation. Here, we review key interactions in the assembly of this 'colicin translocon' and discuss the key role disorder plays in achieving uptake.
Introduction
Colicins are a family of toxins released by Escherichia coli to specifically target and kill neighbouring cells when faced with environmental stress [1] . These protein antibiotics (or bacteriocins) are produced by many other Gram-negative micro-organisms [2] .
Enzymatic E colicins consist of three domains: an Rdomain (receptor-binding domain), a T-domain (translocation domain) and a C-domain (cytotoxic nuclease domain) ( Figure 1 ) [3] . Upon uptake of the colicin, competitor cell killing is achieved via action of the nuclease on DNA (E2, E7, E8 and E9), rRNA (E3, E4 and E6) or tRNA (E5) depending on the family member.
Each nuclease is produced with a cognate inhibitor, an Im (immunity protein). While cognate Im-nuclease interactions occur with extremely high affinity (K d = 10 −15 M), non-cognate interactions span a wide range of affinities (K d = 10 −9 -10 −4 M) [4] [5] [6] . This variation in binding affinity provides the molecular basis for competition. The potency of nuclease action dictates that the Im-DNase/rRNase/tRNase interaction must be extremely tight to offer protection from cell-suicide; neighbouring bacteria that do not possess the correct Im partner (and thus do not possess sufficient 'protection affinity') are left vulnerable to attack.
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R-domain of the colicin, binding of the T-domain to a porin (OmpF) and subsequent translocation driven by recruitment of the Tol system.
In this review, we provide a molecular focus on these protein-protein interactions mediating translocation, in particular those involving the intrinsically disordered T-domain of the ColE9 (colicin E9) and those of the periplasmic protein TolB. It is increasingly apparent that intrinsic disorder plays an important role in diverse biological processes including fibrillogenesis, transcription regulation, hostpathogen interactions and cancer [7] [8] [9] . Here, we highlight, using colicin import as an example, the role disorder can play in translocation and subsequent cell entry.
Colicin binding to OM proteins
Translocation is an energy-driven process and therefore for ColE9 to degrade the bacterial genome it has to: (i) attach itself to a susceptible cell, (ii) tap into an energy source to power translocation, (iii) traverse both the IM (inner membrane) and OM to gain entry to the cytoplasm, and (iv) release the Im protein. Assembly of the translocation machinery begins with the attachment of ColE9 to the OM, through its R-domain, to BtuB. BtuB is a 22-stranded β-barrel that is responsible for the active transport of cobalamin (vitamin B 12 ) through its interaction with the Ton system, but is used by ColE9 as an anchoring point to the OM [10] .
We have shown through ITC (isothermal titration calorimetry) that the affinity of ColE9 for BtuB is tight (K d = 153 nM) [11] . Furthermore, binding is significantly enhanced in the presence of calcium (K d = 2.6 nM). Ca 2+ ions are known to bind to the extracellular loops of BtuB and create a high affinity site for cobalamin and appear to modulate the affinity of BtuB for ColE9 in a similar fashion [12] . and E9), an rRNase (E3, E4 and E6) or a tRNase (E5). Adapted with permission from [3] . c 2001 Elsevier.
Figure 2 Model of the assembled colicin translocon Colicin binds to its primary receptor BtuB through its R-domain (red).
The binary complex recruits OmpF through its intrinsically disordered T-domain (cyan dashes) in order to present an epitope that can compete with Pal for binding TolB. The quaternary complex hitches to the IM complex TolQRA through TolA which triggers immunity release (purple) and nuclease entry (green).
The structure of the R-domain of ColE3 (colicin E3) (from the same family of nuclease toxins) in complex with BtuB shows the colicin binds just above the cobalamin-binding site using the short connecting loop between the coils of the Rdomain [13] . ColE9 is presumed to interact similarly given that both the T-and R-domains of ColE3 and ColE9 share 92% sequence identity. These residues contact five of the extracellular loops of BtuB and a single residue from its plug domain. Binding holds the R-domain at an angle of ∼45
• to the membrane. Modelling full-length colicin on to the Rdomain-BtuB complex places both the T-and C-domains adjacent to the OM (Figure 2) .
With colicin now bound to the OM, but without a source of energy to allow translocation and release of the Im protein, a means of gaining access to the periplasm must be found. Here, the pmf (protonmotive force) that exists across the IM can be exploited. This is achieved through the interaction of the T-domain with the OM protein, OmpF [14] . OmpF is an abundant trimeric porin (approx. 100 000 copies per cell) that allows the diffusion of small cationic molecules across the membrane [15] . Each OmpF monomer consists of a 16-stranded β-barrel, each one being a potential entry route to the periplasm [16] .
The T-domain begins it search for OmpF through its intrinsically disordered region (residues 1-81). Disordered regions are often thought to enhance their chances of productive interaction through the larger Stokes radius conferred by their lack of regular secondary structure. This 'fly-casting' [17] mechanism recruits OmpF to the ColE9-BtuB complex. We first identified OmpF as the port of colicin entry to the periplasm through protection assays [18] and subsequently by membrane extraction of the intact BtuB-ColE9/Im9-OmpF complex [11] . Using truncates of the disordered N-terminus of ColE9, we demonstrated that removal of as few as the first seven residues of the N-terminus resulted in 85% reduction in OmpF recruitment. Only removal of residues 1-60 or internal deletion of residues 60-80 completely abolished ColE9-OmpF binding. This suggests two points of contact between the colicin disordered region and OmpF.
To exploit the pmf of the IM the disordered region of the T-domain must thread through either the OmpF lumen or the interface between OmpF and the lipid bilayer. Recent literature suggests both mechanisms might be possible. Yamashita et al. [19] have solved a crystal structure of OmpF bound to the T-domain of ColE3. This structure shows a stretch of seven amino acids of the T-domain passing through the lumen. The low resolution of the structure [3.0 Å (1 Å = 0.1 nm)], however, precludes side chain assignment and identification of a specific OmpF-binding sequence. By contrast, Baboolal et al. [20] have shown, through electron microscopy difference analysis at 25 Å , that colicin N (a poreforming colicin) interacts at the OmpF surface displacing bound lipopolysaccharide.
Progress through the periplasm
Once through OmpF, recruitment of a periplasmic protein, coupled to the pmf, is thought to be needed. Gene deletion experiments identified the Tol operon as necessary for translocation [21, 22] . The Tol operon consists of five proteins [TolQRAB and Pal (peptidoglycan-associated lipoprotein)] which link the IM to the OM through a series of proteinprotein interactions (Figure 2 ) [23] . TolQRA are IM proteins with TolA spanning the periplasmic space and undergoing a conformational change in response to the pmf [24] . TolB is a periplasmic protein and is composed of two domains, an N-terminal α/β domain and a C-terminal six-bladed β-propeller domain [25, 26] . Pal is not required for colicin translocation but appears to act as a 'stabilizer' between the OM and the peptidoglycan layer. The protein is tethered to the OM through palmitoylation at its N-terminal residue [27] , whereas its globular C-terminal region is free to interact with the peptidoglycan layer [28, 29] and TolB [30] . Deletion of any of the Tol genes causes a tol phenotype: OM blebbing, release of periplasmic content, hypersensitivity to SDS and vancomycin and, importantly, colicin tolerance [31] In vivo and in vitro cross-linking experiments first identified an interaction between the T-domain of ColE3 and TolB [32] . Using yeast-two-hybrid screens and truncations, it was subsequently shown that both ColE9 and ColE3 bind to the C-terminal β-propeller domain of TolB [26, 32] . TolB also engages with two other proteins of the Tol operon: TolA and Pal. Both in vivo and in vitro cross-linking, yeast two-hybrid screens and suppressor mutations have identified that while TolA interacts with the N-terminal domain [33] , Pal interacts through the C-terminal domain of TolB [34] . This suggested possible overlap between the Pal-and ColE9-binding sites. In support of this, certain mutations within TolB were shown to affect both ColE9 and Pal binding [30] . The TolB-binding sequence of ColE9 was narrowed down to five residues (DGSGW) [35, 36] in the T-domain, although we later demonstrated via NMR [37] and deletion analysis [38] that this extends to 16 residues including the DGSGW box.
Disorder and molecular mimicry in the assembly of a colicin translocon
Despite identification of a ColE9-binding site within the TolB sequence it was still unclear how translocation of the colicin might be achieved. By solving the structures of both the TolBColE9 T-domain 32−47 [38] and TolB-Pal [39] complexes, we first demonstrated a potential mechanism for this process, one in which the disordered nature of the T-domain is key.
The structure of the TolB-ColE9 T-domain 32−47 complex shows that ColE9 binds to the C-terminal β-propeller domain and folds into a distorted β-hairpin. Only five of the 21 hydrogen bonds that form upon ColE9 binding are made directly to TolB (a further four through bridging waters). Most of the new hydrogen bonds are intramolecular. The direct interactions that are made by ColE9 are to residues which have been shown through mutation to interact with Pal [30] . Further evidence for ordering of the Tdomain on binding TolB comes from ITC experiments [38] . The interaction of TolB with ColE9 (K d ∼ 1 μM) shows a thermodynamic signature typical of disorder-order transitions, where the large favourable enthalpy of binding overcomes the unfavourable entropy arising from folding.
The affinity of Pal for TolB has also been measured through ITC and was found to be ∼27 nM, 40-fold tighter. This discrepancy between affinities does not explain how ColE9 is able to competitively recruit TolB. Further analysis of the structure, however, sheds light on this. Two Ca 2+ ions (included in the crystallization conditions) are found in the structure of the complex, co-ordinated to the channel, which runs through the β-propeller. Generation of electrostatic surfaces of TolB, with and without the Ca 2+ ions, shows that the canyon floor changes from being positively to negatively charged, respectively, in the vicinity of the Ca 2+ ions. Repeating ITC experiments in the presence of calcium, we observed that this electrostatic switch tightens the TolB-ColE9 interaction and slightly weakens the TolB-Pal interaction (K d ∼ 90 nM for both complexes); this rebalancing allows competitive recruitment of TolB.
To understand how a 16-residue disordered peptide can bind with the same affinity as a 16 kDa globular protein, and to prove that Pal and ColE9 share a common binding site, we solved the structure of the TolB-Pal complex [39] . We found Pal does indeed bind to the β-propeller, but, unlike ColE9 32−47 , induces a large number of conformational changes within TolB upon binding. ColE9 32−47 occupies ∼50% of the surface area buried by Pal and only makes additional contacts through more effective burial of side chains. A comparison of both binding interfaces shows that the colicin actually mimics a key set of interactions made by two turns of a helix in Pal (Figure 3) . We rationalize that ColE9 adopts this fold to: (i) overcome the entropic cost of folding by making extensive intramolecular hydrogen bonds, and (ii) to mimic key interactions by a helix without imposing secondary structure.
Conclusions
Colicins subvert normal uptake mechanisms in bacterial cells both by anchoring to an existing nutrient receptor (BtuB) and by reaching into the cell via a porin (OmpF) to harness energy in order to translocate. We have discussed here how this process is dependent on (i) the engagement of OM receptors (Figure 2) , and (ii) the competitive recruitment of a periplasmic protein (TolB) from its normal binding partner (Pal) through molecular mimicry (Figure 3 ). Both processes are facilitated through native disorder in the colicin.
The assembly of a TolB-OmpF-ColE9/Im9-BtuB complex thus constitutes a (putative) translocon. Through this supramolecular complex the colicin can hitch itself to the pmf of the IM provided by interaction of TolB with the periplasmic domain of TolA ( Figure 2) . As yet, the molecular mechanism of how TolB recruitment of TolA leads to translocation is not known. But it is suspected that the conformational change of TolA in response to the pmf is translated to ColE9 through its interaction with TolB. This would enable entry of ColE9 into the periplasm and ultimately the cytoplasm through the IM AAA + ATPase and protease protein FtsH, where nuclease activity could be unleashed [40] .
